Lung Cancer
A Phase III, multisite, double-blinded randomized trial of BNT327 in combination with chemotherapy (etoposide/carboplatin) compared to atezolizumab in combination with chemotherapy (etoposide/carboplatin) in participants with first-line extensive-stage small-cell lung cancer (BNT327-03)
- Details
ClinicalTrials.gov ID:
NCT06712355
Diagnosis Type:
NA
USOR Number:
- Address
,
P: